Three Protocols Designed to Individualize and Maximize Anti-Cancer Drug Therapy
Arthur J. Weiss, Irwin L. Stoloff

J. Cancer Ther. Vol.6 No.12, November 30, 2015
DOI:10.4236/jct.2015.612120

Frequent Copy Gain of the MET Gene in Hypopharyngeal and Laryngeal Cancer in the Japanese Population
Ken Akashi, Yasuhiro Ebihara, Go Omura, Yuki Saito, Masafumi Yoshida, Mizuo Ando, Takahiro Asakage, Tatsuya Yamasoba, Yoshinori Murakami

J. Cancer Ther. Vol.6 No.12, November 27, 2015
DOI:10.4236/jct.2015.612119

Response of Subcutaneous Xenografts of Endometrial Cancer in Nude Mice to Inhibitors of Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase (MAPK) Pathways: An Effective Therapeutic Strategy for Endometrial Cancer
Ruixia Guo, Xinyan Wang, Ruifang Zhang, Huirong Shi, Yuhuan Qiao, Wenjing Yun, Xin Ge, Yan Lin, Jia Lei

J. Cancer Ther. Vol.6 No.12, November 27, 2015
DOI:10.4236/jct.2015.612118

Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate-Risk Stage IB-IIB Cervical Cancer
Hongwu Wen, Tongyu Liu, Zhaoyi Feng, Weiping Huang, Ke Ma, Xia Tao

J. Cancer Ther. Vol.6 No.12, November 26, 2015
DOI:10.4236/jct.2015.612117

A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski

J. Cancer Ther. Vol.6 No.12, November 25, 2015
DOI:10.4236/jct.2015.612116